New Products
We kindly present our most recent product introductions. Our product pages contain more specific information.
Hydrocortisone tablets (Acecort®/Lilinorm®) licensed in Belgium, Germany, Denmark, Norway and Sweden
Between November 2021 and January 2022 Hydrocortisone tablets in 1 mg, 5 mg and 10 mg were licensed in Belgium, Germany as Acecort. And in Denmark, Norway and Sweden as Lilinorm. Finland is expected soon. Pending national reimbursement applications, introductions are planned mid-2022.
Under brand name Acecort, hydrocortisone tablets have been licensed and available in the Netherlands since 2020.
Refusal® 250 mg tablets (disulfiram)
In December 2021 we introduced Refusal in the Netherlands. The product is well known throughout Europe.
Hydrocortisone ACE 10 mg/ml acetic acid ear drops
In November 2021 we introduced Hydrocortisone ACE 10 mg/ml acetic acid ear drops in the Netherlands. In most other countries, this product is compounded in pharmacies. Now, a licensed alternative is available.
Broxil® licensed in Belgium
Broxil (pheneticillin) is available as capsules of 250 mg and 500 mg as well as 125 mg/5 ml powder for oral suspension. In August 2021 Ace received the Marketing Authorisation for Broxil in Belgium. Pending the reimbursement decision by Riziv, introduction is planned for March 2022. Broxil has been available in the Netherlands since the 1960s.